The U.S. Biden administration recently expressed support for the exemption of the new crown vaccine patent, the British media reported on Sunday (9), some Washington officials and pharmaceutical companies worried that the abandonment of patents will allow China to surpass the U.S. years of research results, erasing the U.S. advantage in the field of biopharmaceuticals.
Washington recently issued a policy paper to pharmaceutical companies, mentioning that the sharing of intellectual property rights may harm the United States competitive advantage over China, but believe that it can be handled through the World Trade Organization negotiations, no detailed account. The negotiations will take place in the coming months, and there is disagreement within Washington over how to discuss these concerns at that time.
Former U.S. Ambassador to China Gary Locke said that Pfizer and Modena have spent years developing these vaccines, and that China, Russia, India, South Africa and other countries want to acquire the technology to make them, with the intention of acquiring the underlying technology to develop other new vaccines.
Recent Comments